SERRAO, ALESSANDRA
SERRAO, ALESSANDRA
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
. BEAM vs FEAM conditioning: retrospective study in lymphoma patients undergoing autologous stem cell transplant.
2018 Marchesi, F.; Capria, S.; Giannarelli, D.; Trisolini, S. M.; Ansuinelli, M.; Caputo, M. D.; Serrao, A.; Gumenyuk, S.; Renzi, D.; Pupo, L.; Palombi, F.; Provenzano, I.; Di Rocco, A.; Pisani, F.; Romano, A.; Spadea, A.; Papa, E.; Canfora, M.; Cantonetti &, M.; Mengarelli, A.
5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials.
2012 Breccia, M; Loglisci, G; Salaroli, A; Serrao, A; Petrucci, L; Mancini, M; Alimena, Giuliana
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms
2020 Serrao, Alessandra; Breccia, Massimo; Napolitano, Mariasanta; Fiori, Luciano; Santoro, Marco; Scalzulli, Emilia; Santopietro, Michelina; Santoro, Cristina; Raso, Simona; Chistolini, Antonio
Adaptive evolution of male accessory gland proteins involved in post-mating reproductive mechanisms of the african malaria mosquito Anopheles gambiae.
2010 Mancini, Emiliano; Tammaro, Federica; Baldini, F.; Serrao, A.; Rogers, D.; Sharakhov, I.; Catteruccia, F.; DELLA TORRE, Alessandra
Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: A single-center experience
2019 Bruzzese, Antonella; Santoro, C.; Baldacci, E.; Ferretti, A.; Pieroni, Simone; Serrao, A.; Foa, R.; Chistolini, A.
Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib.
2014 Breccia, M; Salaroli, A; Serrao, A; Zacheo, I; Saracino, R; Alimena, Giuliana
Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response
2012 Breccia, Massimo; Giuseppina, Loglisci; Laura, Cannella; Paola, Finsinger; Marco, Mancini; Serrao, Alessandra; Michelina, Santopietro; Adriano, Salaroli; Alimena, Giuliana
Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation.
2013 Breccia, M; Salaroli, A; Serrao, A; Alimena, Giuliana
Azacitidine Followed by Radiotherapy as Effective Treatment for Chronic Myelomonocytic Leukemia with Extramedullary Localization.
2013 Serrao, A; Loglisci, G; Salaroli, A; Zacheo, I; Alimena, Giuliana; Breccia, M.
Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry
2022 Antonucci, E.; Barcella, L.; Russo, L.; Chistolini, A.; Serrao, A.; Elmi, G.; Sivera, P.; Falanga, A.; Palareti, G.
Combination of azacitidine and ESA in myelodysplastic patients: The need for prospective studies
2012 Massimo, Breccia; Giuseppina, Loglisci; Adriano, Salaroli; Alessandra, Serrao; Luigi, Petrucci; Irene, Zacheo; Alimena, Giuliana
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
2020 Serrao, Alessandra; Scalzulli, Emilia; Fiori, Luciano; Di Prima, Alessio; Breccia, Massimo; Chistolini, Antonio
Current and future therapeutic approaches for the treatment of follicular lymphoma
2018 Pulsoni, A; Cappelli, Lv; Ballotta, Laura; Canichella, M; Serrao, A; Annechini, G; D'Elia, Gm; Foà, R
Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.
2012 Breccia, M; Serrao, A; Salaroli, A; Loglisci, G; Zacheo, I; Alimena, Giuliana
Deferasirox treatment for myelodysplastic syndromes: "real-life" efficacy and safety in a single-institution patient population.
2012 Breccia, M; Finsinger, P; Loglisci, G; Federico, V; Santopietro, M; Colafigli, G; Petrucci, L; Salaroli, A; Serrao, A; Latagliata, R; Alimena, Giuliana
Delayed cytogenetic and major molecular responses associated to increased BMI at baseline in chronic myeloid leukemia patients treated with imatinib.
2013 Breccia, M; Loglisci, G; Salaroli, A; Serrao, A; Mancini, M; Diverio, D; Latagliata, R; Alimena, Giuliana
Direct oral anticoagulants for the treatment of Mondor's disease not responding to low-molecular weight heparin
2020 Serrao, Alessandra; Lucani, Benedetta; Baldacci, Erminia; Fiori, Luciano; Chistolini, Antonio
Direct oral anticoagulants in patients affected by major congenital thrombophilia
2019 Serrao, A.; Lucani, B.; Mansour, D.; Ferretti, A.; Baldacci, E.; Santoro, C.; Foa, R.; Chistolini, A.
Direct Oral Anticoagulants In Patients With Hematologic Malignancies
2020 Serrao, Alessandra; Fiori, Luciano; Santoro, Cristina; De Luca, Maria Lucia; Ferretti, Antonietta; De Luca, Giulia; Ligia, Silvio; Lapietra, Gianfranco; Mohamed, Sara; Breccia, Massimo; Chistolini, Antonio
Disappearance of fibrosis in secondary myelofibrosis after ruxolitinib treatment: new endpoint to achieve?
2014 Molica, M; Serrao, A; Saracino, R; Zacheo, I; Stingone, C; Alimena, Giuliana; Breccia, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| . BEAM vs FEAM conditioning: retrospective study in lymphoma patients undergoing autologous stem cell transplant. | 2018 | Marchesi, F.; Capria, S.; Giannarelli, D.; Trisolini, S. M.; Ansuinelli, M.; Caputo, M. D.; Serrao, A.; Gumenyuk, S.; Renzi, D.; Pupo, L.; Palombi, F.; Provenzano, I.; Di Rocco, A.; Pisani, F.; Romano, A.; Spadea, A.; Papa, E.; Canfora, M.; Cantonetti &, M.; Mengarelli, A. | |
| 5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials. | 2012 | Breccia, M; Loglisci, G; Salaroli, A; Serrao, A; Petrucci, L; Mancini, M; Alimena, Giuliana | |
| A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms | 2020 | Serrao, Alessandra; Breccia, Massimo; Napolitano, Mariasanta; Fiori, Luciano; Santoro, Marco; Scalzulli, Emilia; Santopietro, Michelina; Santoro, Cristina; Raso, Simona; Chistolini, Antonio | |
| Adaptive evolution of male accessory gland proteins involved in post-mating reproductive mechanisms of the african malaria mosquito Anopheles gambiae. | 2010 | Mancini, Emiliano; Tammaro, Federica; Baldini, F.; Serrao, A.; Rogers, D.; Sharakhov, I.; Catteruccia, F.; DELLA TORRE, Alessandra | |
| Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: A single-center experience | 2019 | Bruzzese, Antonella; Santoro, C.; Baldacci, E.; Ferretti, A.; Pieroni, Simone; Serrao, A.; Foa, R.; Chistolini, A. | |
| Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib. | 2014 | Breccia, M; Salaroli, A; Serrao, A; Zacheo, I; Saracino, R; Alimena, Giuliana | |
| Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response | 2012 | Breccia, Massimo; Giuseppina, Loglisci; Laura, Cannella; Paola, Finsinger; Marco, Mancini; Serrao, Alessandra; Michelina, Santopietro; Adriano, Salaroli; Alimena, Giuliana | |
| Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation. | 2013 | Breccia, M; Salaroli, A; Serrao, A; Alimena, Giuliana | |
| Azacitidine Followed by Radiotherapy as Effective Treatment for Chronic Myelomonocytic Leukemia with Extramedullary Localization. | 2013 | Serrao, A; Loglisci, G; Salaroli, A; Zacheo, I; Alimena, Giuliana; Breccia, M. | |
| Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry | 2022 | Antonucci, E.; Barcella, L.; Russo, L.; Chistolini, A.; Serrao, A.; Elmi, G.; Sivera, P.; Falanga, A.; Palareti, G. | |
| Combination of azacitidine and ESA in myelodysplastic patients: The need for prospective studies | 2012 | Massimo, Breccia; Giuseppina, Loglisci; Adriano, Salaroli; Alessandra, Serrao; Luigi, Petrucci; Irene, Zacheo; Alimena, Giuliana | |
| Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors | 2020 | Serrao, Alessandra; Scalzulli, Emilia; Fiori, Luciano; Di Prima, Alessio; Breccia, Massimo; Chistolini, Antonio | |
| Current and future therapeutic approaches for the treatment of follicular lymphoma | 2018 | Pulsoni, A; Cappelli, Lv; Ballotta, Laura; Canichella, M; Serrao, A; Annechini, G; D'Elia, Gm; Foà, R | |
| Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia. | 2012 | Breccia, M; Serrao, A; Salaroli, A; Loglisci, G; Zacheo, I; Alimena, Giuliana | |
| Deferasirox treatment for myelodysplastic syndromes: "real-life" efficacy and safety in a single-institution patient population. | 2012 | Breccia, M; Finsinger, P; Loglisci, G; Federico, V; Santopietro, M; Colafigli, G; Petrucci, L; Salaroli, A; Serrao, A; Latagliata, R; Alimena, Giuliana | |
| Delayed cytogenetic and major molecular responses associated to increased BMI at baseline in chronic myeloid leukemia patients treated with imatinib. | 2013 | Breccia, M; Loglisci, G; Salaroli, A; Serrao, A; Mancini, M; Diverio, D; Latagliata, R; Alimena, Giuliana | |
| Direct oral anticoagulants for the treatment of Mondor's disease not responding to low-molecular weight heparin | 2020 | Serrao, Alessandra; Lucani, Benedetta; Baldacci, Erminia; Fiori, Luciano; Chistolini, Antonio | |
| Direct oral anticoagulants in patients affected by major congenital thrombophilia | 2019 | Serrao, A.; Lucani, B.; Mansour, D.; Ferretti, A.; Baldacci, E.; Santoro, C.; Foa, R.; Chistolini, A. | |
| Direct Oral Anticoagulants In Patients With Hematologic Malignancies | 2020 | Serrao, Alessandra; Fiori, Luciano; Santoro, Cristina; De Luca, Maria Lucia; Ferretti, Antonietta; De Luca, Giulia; Ligia, Silvio; Lapietra, Gianfranco; Mohamed, Sara; Breccia, Massimo; Chistolini, Antonio | |
| Disappearance of fibrosis in secondary myelofibrosis after ruxolitinib treatment: new endpoint to achieve? | 2014 | Molica, M; Serrao, A; Saracino, R; Zacheo, I; Stingone, C; Alimena, Giuliana; Breccia, M. |